Celiac Disease Market is expected to experience a growth rate of 10.2% CAGR, reaching a value of USD 1,434.2 Million by 2032
Acumen Research and Consulting recently published report titled “Celiac Disease Market Forecast, 2023 – 2032”
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) — The Global Celiac Disease Market size was valued at USD 551.3 Million in 2022 and is projected to reach USD 1,434.2 Million by 2032 mounting at a CAGR of 10.2% from 2023 to 2032.
Celiac Disease Market Highlights and Statistics:
- The Global Celiac Disease Market was valued at USD 551.3 million in 2022 and is projected to reach USD 1,434.2 million by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2032.
- The market is driven by factors including increasing awareness about celiac disease, improved diagnostic capabilities, and the growing prevalence of the disease.
- Based on route of administration, the Oral sub-segment generated around 61% share in 2022
- Focus on patient education and support programs is a popular celiac disease market trend that fuels the industry demand
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/3249
Celiac Disease Market Report Coverage:
| Market | Celiac Disease Market | |
| Celiac Disease Market Size 2022 | USD 551.3 Million | |
| Celiac Disease Market Forecast 2032 | USD 1,434.2 Million | |
| Celiac Disease Market CAGR During 2023 – 2032 | 10.2% | |
| Celiac Disease Market Analysis Period | 2020 – 2032 | |
| Celiac Disease Market Base Year | 2022 | |
| Celiac Disease Market Forecast Data | 2023 – 2032 | |
| Segments Covered | By Treatment, By Route of Administration, By End-User, By Distribution Channel, And By Geography | |
| Celiac Disease Market Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa | |
| Key Companies Profiled | Amgen, Anokion SA, BioLineRx Ltd, ChemoCentryx, Inc, COUR Pharmaceutical, F. Hoffmann-La Roche Ltd, ImmunogenX, LLC, Innovate Biopharmaceuticals, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd. | |
| Report Coverage | Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis | |
Celiac Disease Market Analysis:
The Celiac Disease Market is experiencing significant growth due to increasing awareness, improved diagnostic capabilities, and the rising prevalence of the disease. The market is witnessing trends including rising awareness and diagnosis, expansion of the gluten-free product market, and research and development of therapeutic options. Key drivers include the increasing prevalence of celiac disease, improved diagnostic capabilities, and the growing adoption of gluten-free diets. However, challenges related to lack of awareness and underdiagnosis, as well as stringent gluten-free regulations, need to be addressed. Market segmentation based on diagnostic tests, treatment options, end-users, and geography allows for targeted strategies and customized solutions. The market presents opportunities for key players to develop innovative diagnostic tests, therapies, and gluten-free products to meet the growing demand and improve patient outcomes. The Celiac Disease Market is expected to continue its growth trajectory, driven by the increasing awareness and focus on the management of this chronic autoimmune disorder.
Celiac Disease Market Trends:
- Rising Awareness and Diagnosis: There is a growing awareness of celiac disease among both healthcare professionals and the general population. This has led to increased screening and diagnosis of the disease, resulting in a larger patient pool and driving market growth.
- Gluten-Free Product Market Expansion: The market for gluten-free products has witnessed significant growth, driven by the increasing number of individuals with celiac disease and gluten intolerance. Food manufacturers are introducing a wide range of gluten-free products to cater to this growing demand.
- Research and Development of Therapeutic Options: There is ongoing research and development of therapeutic options for celiac disease, including drug treatments and immunotherapies. These advancements have the potential to revolutionize the management of celiac disease and further fuel market growth.
Celiac Disease Market Growth Drivers:
Increasing Prevalence of Celiac Disease: The prevalence of celiac disease is rising globally, with a significant number of undiagnosed cases. This growing patient population is driving the demand for diagnostic tests, treatments, and gluten-free products, contributing to market growth.
Improved Diagnostic Capabilities: Advancements in diagnostic techniques, including serology testing and genetic testing, have improved the accuracy and efficiency of celiac disease diagnosis. This has led to early detection and timely management of the disease, driving market growth.
Growing Adoption of Gluten-Free Diets: The increasing adoption of gluten-free diets by individuals with celiac disease and gluten intolerance is a significant driver of the market. This has resulted in the expansion of the gluten-free product market, providing more options for individuals with dietary restrictions.
Celiac Disease Market Challenges:
Lack of Awareness and Underdiagnosis: Despite the increasing awareness, celiac disease remains underdiagnosed, and many individuals with the disease go undetected. The lack of awareness among healthcare professionals and the general population poses a challenge to the market.
Stringent Gluten-Free Regulations: The strict regulations and standards associated with gluten-free labeling and manufacturing pose challenges for food manufacturers. Ensuring compliance with these regulations and maintaining product quality can be demanding, affecting market growth.
Check the detailed table of contents of the report @
https://www.acumenresearchandconsulting.com/table-of-content/celiac-disease-market
Celiac Disease Market Segmentation:
Based on the Treatment
- Gluten Free Diet
- Larazotide Acetate
- Infliximab
- Other
Based on the Administration Route
- Parenteral
- Oral
Based on End-User
- Homecare
- Hospitals
- Other
Based on Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Celiac Disease Market Regional Analysis:
North America dominates the Celiac Disease Market due to the high prevalence of celiac disease and the presence of key market players. Europe also holds a significant market share, driven by the rising awareness about the disease and favorable government initiatives. The Asia Pacific region is expected to witness substantial growth due to the increasing diagnosis of celiac disease and the growing demand for gluten-free products.
Buy this premium research report –
https://www.acumenresearchandconsulting.com/buy-now/0/3249
Celiac Disease Market Key Players:
Alba Therapeutics, Biomerica Inc., Celiac Therapeutics Inc., F. Hoffmann-La Roche AG, General Mills Inc., Glutenostics LLC, Hain Celestial Group Inc., Innovate Biopharmaceuticals Inc., Johnson & Johnson and Quest Diagnostics Incorporated.
Browse More Research Topic on Healthcare Sector Related Reports:
The Global Medical Biomimetics Market Size accounted for USD 31.5 Billion in 2022 and is projected to achieve a market size of USD 58.7 Billion by 2032 growing at a CAGR of 6.6% from 2023 to 2032.
The Global Conjunctivitis Treatment Market Size accounted for USD 4.4 Billion in 2022 and is estimated to achieve a market size of USD 6.4 Billion by 2032 growing at a CAGR of 3.9% from 2023 to 2032.
The Global Equine Surgery Market Size accounted for USD 2.8 Billion in 2022 and is estimated to achieve a market size of USD 4.9 Billion by 2032 growing at a CAGR of 6.1% from 2023 to 2032.
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter , Instagram and LinkedIn
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same. 